Pacira BioSciences (PCRX) Assets Average (2011 - 2026)
Pacira BioSciences (PCRX) posted quarterly Assets Average of $1.2 billion for Q1 2026, down 21.23% year-over-year from $1.6 billion in Q1 2025, and down 3.47% quarter-over-quarter from $1.3 billion in Q4 2025.
Pacira BioSciences (PCRX) Assets Average (2011 - 2026) Analysis & Trends
Pacira BioSciences' Assets Average history runs 16 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Assets Average fell 21.23% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (down 21.23% YoY), while the FY2025 annual figure was $1.4 billion, down 9.89% from the prior year.
- Assets Average for Q1 2026 stood at $1.2 billion, down from $1.3 billion in the prior quarter.
- The five-year high for Assets Average was $2.0 billion in Q1 2022, with the low at $1.2 billion in Q1 2026.
- The 5-year median for Assets Average is $1.6 billion (2025), against an average of $1.6 billion.
- The sharpest annual moves came in 2022 and 2026: Assets Average jumped 54.83% in 2022, then slipped 21.23% in 2026.
- Pacira BioSciences' Assets Average stood at $1.7 billion in 2022, then dropped by 8.98% to $1.6 billion in 2023, then fell by 1.08% to $1.5 billion in 2024, then fell by 16.67% to $1.3 billion in 2025, then decreased by 3.47% to $1.2 billion in 2026.
- Business Quant data shows PCRX's Assets Average at $1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 1.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | 1.56 Bn |
| Mar 31, 2025 | 1.57 Bn |
| Dec 31, 2024 | 1.54 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.55 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.53 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 1.71 Bn |
| Sep 30, 2022 | 1.73 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.98 Bn |
| Dec 31, 2021 | 1.72 Bn |
| Sep 30, 2021 | 1.34 Bn |